Medical Education Resources, Inc.


Global Management of Chronic Renal Insufficiency:
Practical Issues

Post-Test Answer Sheet and Evaluation Form


Please mark and submit your answers on the Post-Test / Evaluation Form . After reviewing the web posting carefully, indicate your answers to the quiz questions on the answer sheet. There is only one correct answer for each question. Circle the letter on the answer sheet representing the best answer to each question.

CME Questions

1. The best overall measure of kidney function is:
a. Measuring TSAT levels
b. GFR - glomerular filtration rate
c. Determining creatinine levels
d. None of the above

2. The following is not a complication of chronic kidney disease in adults:
a. Hypertension
b. Neurologic changes
c. Anemia
d. Hypotension

3. Studies examining cardiovascular disease have shown that patients on dialysis had a much higher mortality rate compared to the general population.
a. True
b. False

4. A new K/DOQI classification for chronic kidney disease was developed to:
a. Define uniform terms
b. Improve clinical and public information
c. Enhance the conduct of research
d. All of the above

5. A patient is classified as having chronic kidney disease, regardless of evidence of kidney damage, when the GFR is below:
a. 6.6-7.5mL/min/1.73m2
b. 90 mL/min/1.73 m2
c. 60 mL/min/1.73 m2
d. 75 mL/min/1.73 m2

6. As the level of kidney function declines:
a. Phosphorus levels remain the same
b. Calcium levels decrease
c. Parathyroid hormone (PTH) levels increase
d. All of the above

7. According to United States Renal Data System, the number of patients having a hematocrit between 33 and 36 is?
a. 75%
b. 90%
c. 45%
d. 65%

8. Which is not a high risk factor in chronic kidney disease?
a. Right ventricular disorders
b. Arteriosclerosis
c. Atherosclerosis
d. Left ventricular disorders

9. Cardiovascular disease often begins prior to the stage of reduced GFR.
a. True
b. False

10. Anemia, which is risk factor for cardiovascular disease, results in:
a. Increased erythrocytes
b. Decreased heart rate
c. Decreased oxygen delivery
d. Increased viscosity

11. Which of the following has demonstrated a greater number of adverse events?
a. Ferric gluconate
b. Iron dextran
c. Iron sucrose
d. None of the above

12. The potential impact of free iron does not include:
a. Oxidative tissue damage
b. Accelerated tissue damage
c. Higher transferrin levels
d. Enhanced bacterial growth

13. A study by Parkkinen et al examining iron sucrose, free iron and infection determined that ____ mg IVP may be too large a dose of iron sucrose.
a. 75
b. 90
c. 85
d. 100